funding: health foundation, esvs the gala trial general versus local anaesthesia for carotid...
TRANSCRIPT
Funding: Health Foundation, ESVS
The GALA Trial
General versus Local Anaesthesia for Carotid Endarterectomy
Michael J Gough
on behalf of the GALA Trial Collaborators
Discussants: Michael Gough, Michael Horrocks
Funding: Health Foundation, ESVS
Local Versus General Anaesthesia in Carotid Endarterectomy:a Systematic Review of the EvidenceC. Tangkanakul, C. E. Counsell, C. P. Warlow
Eur J Vasc Endovasc Surg 1997, 13: 491-499
The Differing Effects of Regional and General Anaesthesia onCerebral Metabolism During Carotid EndarterectomyA.J. McCleary, N. M. Dearden, D. H. Dickson, A. Watson, M. J. Gough
Eur J Vasc Endovasc Surg 1996, 12: 173-181
Introduction
Funding: Health Foundation, ESVS
Methods
• Eligibility
15 CEAs/surgeon/year + 10 LA
symptomatic or asymptomatic
uncertainty re: best method
co-operate with awake testing
no other surgery
randomise only once
• Randomisation
Stratified by centre
Telephone, Fax, Web
• Surgery
GA: follow normal practice
LA: shunt only on basis awake test testing
Monitoring, GA shunts, patch endarterectomy, as per normal
• Follow-up
Post-discharge/death form: 7 days
1 month: examination by “blind” independent neurologist
12 month FU: telephone, questionnaire, face-face
Funding: Health Foundation, ESVS
• Primary end points:
Stroke (retinal infarct)MI (fatal or non-
fatal)
Death
Analysis intention-to-treat
Funding: Health Foundation, ESVS
3526 randomised(95 centres, 24 countries)
GA1753 allocated: 1628 GA
31 no anaesthesia - 92 cross-over2 unknown
LA1773 allocated: 1655 LA
41 no anaesthesia - 75 cross-over2 unknown
1752 for primary outcome
21 incomplete FU 19 no 1m physician form
1771 for primary outcome
21 incomplete FU19 no 1m physician form
99.9% FU
Funding: Health Foundation, ESVS
Baseline Data
General Local
Age 70 (sd 9) 69 (sd 9)
Male 1232 (70%) 1256 (71%)
Asymptomatic stenosis 685 (39%) 677 (38%)
Mean % stenosis 81 (sd 11) 81 (sd 11)
Contralateral ICA occlusion 150 (9%) 160 (9%)
Smoking, PAD, CAD, AF, DM all equal
Funding: Health Foundation, ESVS
Compliance – No anaesthesia
Reasons:General (n=31)
Local (n=41)
Stroke/Death before operation 2 2
Carotid artery occlusion 8 8
Too ill (unrelated) 7 6
Stenosis/symptoms too mild 4 11
Patient refused 9 13
Carotid stent instead 1 1
Consent early – Randomise late
Funding: Health Foundation, ESVS
Compliance – Cross-overs
Reasons:General (n=92)
Local (n=75)
Medical decision 41 20
Administrative issues 15 9
Patient’s decision 29 44
Reason unknown 7 2
Funding: Health Foundation, ESVS
Conversions
Reasons: Local (n=69)
After start of anaesthesia, pre-surgery
Patient’s decision 6
Problem with position on table etc 3
Patient deteriorated after local block 8
After start of surgery
Pain at operative site 9
Discomfort, anxiety, claustrophobia 25
Physiological instability 5
Protracted or difficult surgery 6
Neurological deterioration on cross-clamping 7
Funding: Health Foundation, ESVS
Primary outcome events
70 66
4 9510
0%
1%
2%
3%
4%
5%
General
84/1752 (4.8%)
Local
80/1771 (4.5%)
Other deaths
MI (fatal ornon-fatal)
Stroke (fatalor non-fatal)
Funding: Health Foundation, ESVS
Primary outcome events
Stroke 3 (-10 to +16)
MI -4(-8 to +2)
Death (any cause) 4 (-3 to +12)
Stroke or death 4 (-9 to +18)
Stroke, MI or death 3 (-11 to +17)
Favours General Favours Local
Events prevented/1000 (95% CI)
-20 -10 0 10 20
Funding: Health Foundation, ESVS
Other Complications
General Local
Cranial nerve injuries 184 (11%) 213 (12%)
Wound haematoma 146 (8%) 150 (8%)
Wound haematoma requiring reoperation
45 (3%) 40 (2%)
Funding: Health Foundation, ESVS
Survival analysis
0%
2%
4%
6%
8%
10%
12%
14%
0 6 12Months since randomisation
% o
f pat
ient
s w
ith e
vent
.
General
Local
Number at risk: General Local
1752 1241 736 1771 1269 751
P=0.094
Funding: Health Foundation, ESVS
Subgroups (primary outcome)
Subgroup General Local P(% ) (% )
Contralateral carotid Yes 10.0% 5.0% 0.098occlusion No 4.3% 4.5%
Age (years) >75 5.3% 4.6% 0.741<=75 4.6% 4.5%
Baseline surgical High 4.1% 4.6% 0.933risk Medium 5.1% 4.9%
Low 4.7% 4.2%
Favours LA Favours GA
Odds ratio and 95% Confidence interval
0.1 1 10
Funding: Health Foundation, ESVS
Implications of GALA Stroke & Death
0.1 1 10
Favours Local Favours General
Meta-analysis of 7 earlier trials
GALA
Meta-analysis including GALA
OR (95% CI)
0.62 (0.24 to 1.59)
0.88 (0.64 to 1.23)
0.85 (0.63 to 1.16)
Funding: Health Foundation, ESVS
Implications of GALA Death
0.01 0.1 1 10 100
Favours Local Favours General
Meta-analysis of 7 earlier trials
GALA
Meta-analysis including GALA
OR (95% CI)
0.23 (0.05 - 1.01)
0.72 (0.40 - 1.30)
0.62 (0.36 – 1.07)
Funding: Health Foundation, ESVS
Primary outcome events(according to anaesthetic received)
0
1
2
3
4
5
GA LA
79/16214.9% 64/1575
4.1%
8 events prevented/1000 (95% CI: -6 to +23)
Funding: Health Foundation, ESVS
Confounding Factors
0
10
20
30
40
50
GA LA
P<0.001
BP manipulated up
25
30
35
40
45
50
GA LA
P<0.001
Patch angioplasty
Funding: Health Foundation, ESVS
Conclusions
• Primary outcomes: no reason to prefer LA or GA
• Secondary outcomes: no influence on length of stay or QOL
• Sub-groups: trend favouring LA for contralateral occlusion
• Trends favouring LA: Peri-operative deathEvent free survival to 1 year
• Implications: Offer both LA & GA for patient preference or medical reasons